Navigation Links
Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $308 Million in Arkansas
Date:11/16/2011

brand copay coupons by government workers in state and municipal employee health programs."

Drug companies profit from coupon promotions in several ways:

  • Copay coupons induce consumers to choose higher-cost brands (despite higher copays) over lower-cost competitors (despite lower copays).  When consumers redeem copay coupons, the drug companies process them through a "shadow claims system" that prevents employers and other plan sponsors from knowing when enrollees have used them.
  • Drug companies often require consumers to submit confidential, personal information in order to redeem copay coupons.  Manufacturers have long sought (but found difficult to obtain) such sensitive patient data, which enables them to identify and directly target individual patients with "brand loyalty" marketing programs.

Coupons can also increase consumer costs in several ways:

  • To help cover the $4 billion spent annually on copay coupons nationally, manufacturers can simply raise prices.  Manufacturers reportedly earn a 4:1 to 6:1 return on investment (ROI) on copay coupon programs.
  • Copay coupons create "brand loyalty" to the most expensive products in each therapeutic class of drugs, even among newly diagnosed patients.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $447 Million in Connecticut
2. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $2.1 Billion in Florida
3. Report: Brand Drug Copay Coupons Raise Health Costs for Employers, Unions, and State Governments by $32 Billion
4. UBM Live to Roll Out Pharma Contract Services & Outsourcing Brand in the US in 2012
5. Popular Sleep Supplement Brand Settles Patent Infringement Suit Against Store Brand Manufacturer
6. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
7. A New Constant Companion: BodyMedia® Enlists Americas Toughest Trainer, Jillian Michaels, as a Brand Partner
8. DreamBrands New Formula Helps Men Feel Younger and Stronger While Naturally Raising Low-T Without Prescription Drugs
9. Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients
10. Why the Brand Surgical Institute in L.A. is Fast Becoming the Authority on Weight Loss Surgery
11. U.S. Branding Group Ltd. to Sponsor DigiPharm Europe 2011, Showcase PharmaDrive™ USB Insert™ Paper Webkey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today it has received a positive ... continue enrolling into the company,s Phase 2 study ... as a treatment for oral mucositis in patients ...
(Date:3/2/2015)... , March 2, 2015 Amgen (NASDAQ: ... 15 abstracts, including data evaluating Repatha TM (evolocumab), ... an investigational drug for chronic heart failure, at the ... Scientific Session (ACC.15), being held March 14-16 in ... a fully human monoclonal antibody that inhibits proprotein convertase ...
(Date:3/2/2015)...  Compass Diversified Holdings (NYSE: CODI ) ... leading middle market businesses, announced today its consolidated operating ... 31, 2014. Fourth Quarter 2014 Highlights ... ("CAD" or "Cash Flow") of $17.5 million for the ... full year 2014;  , Reported net income of ...
Breaking Medicine Technology:Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 2Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 3Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 4Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 5Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 6Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 7Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 8Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 9Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 10Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15
... SILVER SPRING, Md., Nov. 30, 2011 The U.S. ... version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets). ... Ranbaxy Laboratories Ltd. has gained approval to make generic ... mg, and 80 mg strengths. The drug will be ...
... PRINCETON, N.J., Nov. 30, 2011 IntegriChain, Inc., a ... by Forbes as #19 on the list of America,s ... services to help customers improve order forecasting, order monitoring, ... planning. IntegriChain has grown 60% over the past three ...
Cached Medicine Technology:FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 2FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 3Forbes Announces IntegriChain in Top 20 on List of America's Most Promising Companies 2
(Date:3/3/2015)... Angeles, CA (PRWEB) March 03, 2015 ... Boost , a fast weight loss product that is ... country. This is because it contains ingredients that help ... Boost is a new combination diet product thought to ... Metabolism Boost contains three ingredients, all directed at ...
(Date:3/3/2015)... Dallas, TX (PRWEB) March 03, 2015 ... Janie Schumaker, RN, BSN, MBA, CEN, CPHQ, FABC as ... commitment to clinically-focused innovation for unscheduled, episodic care. ... to care, making episodic care settings including urgent care ... market segments in healthcare,” said Roger Davis, T-System’s chief ...
(Date:3/3/2015)... The Forbes Living producers are ... when planning an Eco-vacation. It will review the basics ... The segment will explore the greenest ground transportation options, ... policy, request Earth-friendly choices along the way, and much ... to save electricity while away. More people are searching ...
(Date:3/3/2015)... 2015 The Data 360 Conference ... Ford Conference Center, Dearborn, MI, on March 5, 2015. ... a featured speaker. He is known internationally as “The Father ... These designations were earned due to years of R&D on ... DB, released over 10 years ago. Subsequent developments in Big ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 First ... freestanding emergency rooms in the United States, named Jeffrey ... its Louetta facility. , “We are pleased to ... of our Louetta facility,” said Dr. James M. Muzzarelli, ... , Dr. Smaistrla received his undergraduate and medical degrees ...
Breaking Medicine News(10 mins):Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 4Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Forbes Living Segment on Planning an Eco-Vacation in the Works 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:First Choice Emergency Room Announces Dr. Jeffrey Smaistrla as New Medical Director of LouettaFacility 2
... is often referred to as the fifth vital sign. ... other critical care settings cannot be doubted. Pulse oximetry ... of years and recent advances have made the process ... accurate. However, the pulse oximetry market faces the same ...
... With ... but in a recent literature study published in the July/August issue of Sports Health: ... disease. , ... (Vocus) June 24, 2009 -- With skin cancer rates on the increase, most individuals know ...
... ... on clinical nutrition and preventive medicine, is now a featured expert on searchjointpain.com, a new ... , ... 2009 -- Susan Lark, MD, an eminent authority on clinical nutrition and preventive medicine, is ...
... ... an optimal nutritional supplement to support overall health and laminitis prevention for at-risk horses. ... Shenandoah, IA (PRWEB) June 24, ... of these horses are insulin resistant, and as such are at a higher risk for ...
... , ... Survey confirms that online scheduling converts Internet surfers into new customers, provides customer ... ... 2009 -- Appointment-Plus ( www.appointment-plus.com ), the industry leader in web-based scheduling software, ...
... ... could barely keep up with demand to sample and learn about their new products at ... entire day. , ... TX (PRWEB) June 24, 2009 -- Bariatric Advantage, a Division of Catalina Lifesciences, could barely ...
Cached Medicine News:Health News:Pulse Oximetry Entrenched as Standard-of-Care in Patient Monitoring, States Frost & Sullivan 2Health News:Pulse Oximetry Entrenched as Standard-of-Care in Patient Monitoring, States Frost & Sullivan 3Health News:Pulse Oximetry Entrenched as Standard-of-Care in Patient Monitoring, States Frost & Sullivan 4Health News:Study Finds Skin Cancer Rates Higher Among Athletes 2Health News:Women's Health Expert Dr. Susan Lark Featured on Searchjointpain.com 2Health News:Equine Obesity is Associated with Significant Health Issues, Including Insulin Resistance and Laminitis 2Health News:Web-based Scheduling Software is the New Online Shopping Cart for Services 2Health News:Web-based Scheduling Software is the New Online Shopping Cart for Services 3Health News:Interest in the Bariatric Advantage Chewy Bites and Other New Products is at an All-Time High at the ASMBS Conference 2
... POLYGRAM NET™ (PNET) works with the ... analyze pressure and EMG signals from ... graphic format. The PNET software and ... or water-perfused manometry catheters as well ...
... BloodSTOP hemostatic gauze is a revolutionary hypoallergenic ... from biologically inert natural regenerated cellulose. Whether ... safely and quickly stops bleeding. When BloodSTOP ... with blood platelets and fibrin to form ...
Capillaries available in glass and "non-PVC" plastic. Match different analyzer requirements. Variety of sizes match sample-volume requirements of individual analyzers....
... high-efficiency network for your cardiology department designed ... expandable platform., If your requirements are to:, ... images in real-time (25/30 f/s), Distribute result ... of speed, Connect several cardiac cath labs ...
Medicine Products: